Specialists at the American Epilepsy Society’s annual meeting (AES 2021) discussed important new data on issues such as genetic testing, telemedicine, COVID-19, and treatment choices.
Here, Dr William Davis Gaillard (Children’s National Hospital, Washington, DC, USA, and Past-President of the AES) provides commentary on highlights from the meeting, held in Chicago on 3-7 December.
Click on the links in the text for more details of the selected presentations, from Neurodiem’s daily coverage of AES 2021.
A major theme at AES 2021 was the important role of big data in revolutionizing research and rapidly advancing our understanding of epilepsy.